Patent 9193763 was granted and assigned to Purdue Research Foundation on November, 2015 by the United States Patent and Trademark Office.
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.